27 November, 2020
The Royal College of Pathologists of Australasia (RCPA) is delighted that one of its Fellows, Professor Richard Scolyer has been awarded "Outstanding Researcher of the Year" in the NSW Premier's Awards for Outstanding Cancer Research 2020, presented by NSW Cancer Institute. This is one of the biggest awards of its kind that a researcher can receive and marks the first time that a pathologist has ever received this honour.
20 October, 2020
Following an application by the Royal College of Pathologists of Australasia (RCPA), the Medical Services Advisory Committee (MSAC) has recommended to the Health Minister, Greg Hunt, that reproductive carrier screening for fragile X syndrome (FXS), spinal muscular atrophy (SMA) and cystic fibrosis (CF) be listed on the Medicare Benefits Schedule (MBS).
8 July, 2020
The Royal College of Pathologists of Australasia (RCPA) is pleased to announce that, according
to the 2019 Journal Citation Reports (JCR), Pathology, the RCPA’s official journal, has increased
its impact factor to 3.744, which is an increase of 18.4% on the previous year. In addition, the
overall ranking of Pathology has increased, soaring five places to be listed 16 out of 78
pathology titles.
9 June, 2020
As social distancing measures begin to ease, the Royal College of Pathologists of Australasia (RCPA) explains that maintaining high levels Polymerase Chain Reaction (PCR) tests for COVID-19, and an effective public health approach, is key to managing the risk of new outbreaks in Australia and New Zealand.
25 May, 2020
The Royal College of Pathologists of Australasia (RCPA) is pleased to announce that genetic tests to identify heritable mutations, which increase the risk of developing colorectal and endometrial cancer, are now available on the Medicare Benefits Schedule (MBS). This addition to the MBS follows an application by the RCPA to the Medical Services Advisory Committee (MSAC).